한빛사논문
Lee, Yeongjoo MD; Yoo, Ie Ryung MD, PhD; Ha, Seunggyun MD, PhD
From the Division of Nuclear Medicine, Department of Radiology, Seoul St Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
Correspondence to: Ie Ryung Yoo, MD, PhD
Abstract
The clinical value of 16α-18F-fluoro-17 β-estradiol (18F-FES) PET in breast cancer has been widely investigated because it can visualize estrogen receptor-expressing lesions. This relatively new radiotracer adds clinical values by characterization of metastasis in double primary cancer. It also has advantage in finding small brain lesions, which has no background brain activity. Here, we present 18F-FES PET findings of brain and leptomeningeal metastases in a patient with breast and lung malignancy.
논문정보
관련 링크
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기